Search Results

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter ended March 31, 2024.

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, provided a regulatory update on the status of its product development initiative for Re-Tain®.

ImmuCell Corporation announced preliminary, unaudited sales results for the first quarter of 2024, which ended March 31, 2024.

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter and year ended December 31, 2023.

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, announced preliminary, unaudited sales results for the fourth quarter of 2023, which ended December 31, 2023.

ImmuCell Corporation expects to report unaudited financial results for the quarter ended September 30, 2023 after the market closes on Monday, November 13, 2023.